市場調查報告書
商品編碼
1383405
到 2030 年慢性病管理市場預測:按類型、疾病類型、最終用戶和地區進行的全球分析Chronic Disease Management Market Forecasts to 2030 - Global Analysis By Type, Disease Type, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球慢性病管理市場規模為 63 億美元,預計在預測期內將以 13.8% 的年複合成長率成長,到 2030 年達到 156 億美元。
慢性病管理市場是一個處理糖尿病、心臟病和癌症等長期非傳染性疾病的醫療保健部門。它包括旨在預防、監測和治療這些疾病以改善患者生活品質的各種策略和技術。應用包括遠端患者監測、個體化治療計劃和資料驅動的主導。
根據 NCBI 的數據,慢性病約佔死亡原因的 60% 和全球疾病負擔的 43%。
隨著人口結構轉向老化趨勢轉變,慢性病的盛行率正在增加。這種人口趨勢給醫療保健系統和資源帶來了巨大壓力,需要加強疾病管理策略。對慢性病的專業照護、預防措施和長期支持的需求不斷增加,推動了客製化醫療解決方案和技術的發展。解決人口高齡化的醫療保健需求不僅會改善老年人的生活品質,而且在提供有效和高效的護理、推動慢性病管理市場的成長方面也變得越來越重要。
最尖端科技、遠端監控系統和個體化治療解決方案的開發和實施往往需要大量的財務投資。醫療保健組織和提供者經常面臨預算限制以及分配資源來部署昂貴技術的挑戰。此外,這些費用可能會增加患者負擔並限制獲得先進的慢性病管理。經濟負擔也會阻礙小型醫療機構和服務不足的社區提供全面的疾病管理服務,從而加劇健康差距。減少這些成本障礙對於確保公平獲得有效的慢性病管理解決方案至關重要。
世界各地許多政府都認知到慢性病增加對經濟和公共衛生的影響。因此,我們實施了鼓勵開發和採用創新疾病管理解決方案的政策。獎勵包括財政支持、報銷計劃和法律規範,以促進將技術和遠端醫療涵蓋衛生系統,並使提供者更容易提供有效的慢性病管理服務。此類政策不僅促進市場成長,還有助於改善醫療保健的可及性、降低醫療保健成本並改善患者的治療效果,為醫療相關人員和患者創造雙贏的局面。
法規對於確保病患安全和資料安全至關重要,但過於複雜和限制性的法規環境會抑制創新,並可能阻礙管理慢性病的新技術和解決方案的快速開發和部署。合規性挑戰會增加將產品推向市場的時間和成本,並為公司和醫療保健提供者製造障礙。此外,複雜的法規環境可能會阻礙市場進入、限制競爭並限制先進慢性病管理解決方案的使用,最終影響病患照護和醫療保健系統,影響效率。
COVID-19 的疫情對慢性病管理市場產生了重大影響。由於醫療保健系統專注於應對這一流行病,常規慢性病護理已被打亂。遠端醫療和遠端監控解決方案越來越受到關注,以最大限度地減少現場就診並降低弱勢群體的暴露風險。然而,由於資源被轉用於與大流行相關的配合措施,並且常規篩檢和治療被推遲,未控制的慢性病的數量可能會增加,引發人們對長期健康影響的擔憂。這場大流行加速了數位健康解決方案的採用,並凸顯了對有彈性和適應性的慢性病管理策略的需求。
預計服務業市場將出現良好成長。該市場的服務包括廣泛的醫療保健服務,旨在滿足患有長期健康問題的個人的需求。這些服務包括疾病預防和教育、診斷測試、治療計劃、藥物管理和生活方式諮詢。醫療保健提供者正在利用遠端監控、遠端醫療諮詢和資料主導干涉等技術來提供以患者為中心的護理,以有效追蹤和管理慢性病。支持團體和心理健康服務在解決慢性病患者的情緒和心理方面也發揮著重要作用。
預計糖尿病領域在預測期內將以最快的年複合成長率成長。由於其廣泛盛行率和綜合管理的需要,糖尿病已成為慢性病的焦點。這種以高血糖值為特徵的慢性疾病需要持續監測、生活方式調整,通常還需要藥物和胰島素治療。醫療保健提供者和數位健康解決方案提供各種服務,包括血糖監測設備、糖尿病教育計劃、個人化用餐和運動計劃以及遠距醫療諮詢。目的是幫助糖尿病患者更好地管理他們的病情,降低併發症的風險並提高他們的整體生活品質。
預計北美市場在預測期內將繼續佔據大部分市場佔有率。該地區包括美國和加拿大,高齡化、文明病和慢性病負擔的增加正在推動對創新疾病管理解決方案的需求。遠端醫療、穿戴式裝置和電子健康記錄擴大被採用,從而實現遠端監控和個人化護理。此外,在北美,政府政策和醫療保健法規經常鼓勵慢性病管理計劃的製定和實施,從而促進醫療保健創新的發展,重點是改善患者的治療結果和減少慢性病的經濟影響。 。
預計亞太地區在預測期內年複合成長率最高。該地區人口眾多、中階不斷壯大以及生活方式的改變正在增加糖尿病、心血管疾病和呼吸系統疾病等慢性病的盛行率。醫療保健提供者和技術公司正在積極推出疾病預防、監測和治療的創新解決方案。遠端醫療服務、行動健康應用程式和遠端監控設備越來越受歡迎,尤其是在中國和印度等國家。政府旨在改善醫療保健可近性和提高患者對管理慢性病重要性的認知的配合措施正在促進市場擴張。
According to Stratistics MRC, the Global Chronic Disease Management Market is accounted for $6.3 billion in 2023 and is expected to reach $15.6 billion by 2030 growing at a CAGR of 13.8% during the forecast period. The Chronic Disease Management Market is the healthcare sector dedicated to addressing long-term, non-communicable health conditions such as diabetes, heart disease, and cancer. It involves a range of strategies and technologies aimed at preventing, monitoring, and treating these conditions to improve patients' quality of life. Its uses include remote patient monitoring, personalized treatment plans, and data-driven interventions.
According to NCBI, chronic diseases account for about 60% of deaths and 43% of the global disease burden.
As demographics shift towards an older populace, there is a heightened prevalence of chronic diseases, as many of these conditions become more common with age. This demographic trend places a substantial burden on healthcare systems and resources, necessitating enhanced disease management strategies. The demand for specialized care, preventive measures, and long-term support for chronic illnesses is on the rise, fostering the development of tailored healthcare solutions and technologies. Addressing the healthcare needs of the aging population not only improves their quality of life but also drives the growth of the chronic disease management market as it becomes increasingly essential in providing effective and efficient care.
Developing and deploying cutting-edge technologies, remote monitoring systems, and personalized treatment solutions often require substantial financial investments. Healthcare organizations and providers may be constrained by budget limitations and face challenges in allocating resources for the adoption of expensive technologies. Additionally, these costs can translate to higher expenses for patients, limiting their access to advanced chronic disease management. The financial burden may also deter smaller healthcare facilities and underserved regions from offering comprehensive disease management services, potentially exacerbating health disparities. Mitigating these cost barriers is essential to ensure equitable access to effective chronic disease management solutions.
Many governments worldwide are recognizing the economic and public health implications of rising chronic disease burdens. As a result, they are implementing policies that encourage the development and adoption of innovative disease management solutions. Incentives may include financial support, reimbursement programs, and regulatory frameworks that promote the integration of technology and telehealth into healthcare systems, making it easier for providers to offer effective chronic disease management services. These policies not only stimulate market growth but also contribute to better access to care, reduced healthcare costs, and improved patient outcomes, creating a win-win scenario for healthcare stakeholders and patients alike.
While regulations are essential for ensuring patient safety and data security, an overly complex and restrictive regulatory environment can impede innovation and hinder the rapid development and deployment of new technologies and solutions for managing chronic diseases. Compliance challenges can increase the time and cost of bringing products to market, creating barriers for businesses and healthcare providers. Additionally, navigating a complex regulatory landscape may deter some companies from entering the market, limiting competition and potentially limiting the availability of advanced chronic disease management solutions, ultimately impacting patient care and healthcare system efficiency.
The COVID-19 pandemic has had a profound impact on the Chronic Disease Management Market. With healthcare systems focused on responding to the pandemic, there has been a disruption in routine chronic disease care. Telemedicine and remote monitoring solutions gained prominence to minimize in-person visits and reduce exposure risks for vulnerable populations. However, the diversion of resources towards pandemic-related efforts and delays in routine screenings and treatments has led to a potential increase in unmanaged chronic conditions, which may have long-term health implications. The pandemic has accelerated the adoption of digital health solutions while highlighting the need for resilient and adaptable chronic disease management strategies.
The services segment is expected to have lucrative growth in the market. Services in the market encompass a wide range of healthcare offerings tailored to address the needs of individuals dealing with long-term health conditions. These services include disease prevention and education, diagnostic testing, treatment planning, medication management, and lifestyle counseling. Healthcare providers offer patient-centered care by leveraging technology for remote monitoring, telehealth consultations, and data-driven interventions to track and manage chronic diseases effectively. Support groups and mental health services also play a vital role in addressing the emotional and psychological aspects of living with a chronic condition.
The diabetes segment is anticipated to witness the fastest CAGR growth during the forecast period. Diabetes is a central focus in the chronic disease, given its widespread prevalence and the need for comprehensive management. This chronic condition, characterized by high blood sugar levels, requires ongoing monitoring, lifestyle adjustments, and often medication or insulin therapy. Healthcare providers and digital health solutions offer a range of services, including glucose monitoring devices, diabetic education programs, personalized dietary and exercise plans, and telehealth consultations. The goal is to empower individuals with diabetes to better manage their condition, reduce the risk of complications, and improve their overall quality of life.
During the forecast period, it is expected that the North American market will continue to hold a majority of the market share. The region encompasses the United States and Canada, where the aging population, lifestyle-related diseases, and the rising burden of chronic illnesses drive the demand for innovative disease management solutions. The adoption of telehealth, wearable devices, and electronic health records is widespread, enabling remote monitoring and personalized care. Additionally, government policies and healthcare regulations in North America often encourage the development and implementation of chronic disease management programs, making it a fertile ground for healthcare innovation, with a focus on improving patient outcomes and reducing the economic impact of chronic diseases.
Asia Pacific is projected to have the highest CAGR over the forecast period. The region's significant population, rising middle class and lifestyle changes have led to an increasing prevalence of chronic diseases like diabetes, cardiovascular conditions, and respiratory disorders. Healthcare providers and technology companies are actively introducing innovative solutions for disease prevention, monitoring, and treatment. Telehealth services, mobile health apps, and remote monitoring devices are gaining traction, especially in countries like China and India. Government initiatives to improve healthcare access and the growing awareness among patients about the importance of managing chronic conditions contribute to the market's expansion.
Some of the key players in Chronic Disease Management market include: HealthSmart Holdings, Inc., Vivify Health, Inc, Medecision, Inc., Pegasystems Inc., Allscripts Healthcare Solutions, Inc., Altruista Health, AxisPoint Health, Epic Corporation Inc., TriZetto Corporation, EXL Healthcare, ZeOmega Inc. and Health Catalyst.
In January 2023, MedStar Health and Zephyr AI, Inc. a start-up specializing in precision medicine technology announced their partnership to work to improve outcomes for chronic diseases, beginning with type 2 diabetes (T2D).
In October 2022, Enli Health Intelligence, a supplier of digital solutions for population health management, was acquired by Cedar Gate Technologies. With the addition of cohort, population, and patient management technologies, risk & quality indicators, gaps in care identification, and patient outreach opportunities, Cedar Gate's enterprise value-based care platform was intended to be expanded for improved outcomes and long-term financial viability.